Endocrine Hypertension
A Simple and Accurate Solution for the Assessment of Endocrine Hypertension.
A Simple and Accurate Solution for the Assessment of Endocrine Hypertension.
30% of the adult population suffer from hypertension and in 15-20% of these patients it may be due to endocrine causes, such as Primary Aldosteronism (PA). In another 5% of patients the elevated blood pressure is due to Renovascular Hypertension. 1 – 3
In PA excess, aldosterone levels may be produced due to an adenoma (Conn’s syndrome) or hyperplasia. Patients with this condition are at a stronger risk of heart disease and stroke than those with essential hypertension. 4 PA patients also have higher cardiovascular morbidity and mortality than age and sex-matched patients with essential hypertension.
Clinical guidelines recommended Aldosterone to Renin ratio (ARR) as a simple and effective screening test for the presence of PA.5 Renin itself can also be used to stratify risk in essential hypertension patients.
The ARR can be determined from a single plasma sample tube, to facilitate laboratory workflow efficiency:
Filter Products
Type
Portfolio
Panel
Platform
Certification
Assays | Certification | Platform | Clinical Area | Portfolio | RUO/IVD |
---|---|---|---|---|---|
IDS-iSYS Aldosterone | CE MarkedFDA Cleared | i10iSYS | Endocrine Hypertension | Endocrinology | IVD |
IDS-iSYS Direct Renin | CE MarkedFDA Cleared | i10iSYS | Endocrine Hypertension | Endocrinology | IVD |